Sort   by:  
 Page size 
UnknownComparison Shows that Multiplex Polymerase Chain Reaction Identifies Infection-associated Urinary Biomarker-positive Urinary Tract Infections That Are Missed by Standard Urine Culture.
Not available
S-EPMC10751541 | biostudies-literature
UnknownMiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling.
Not available
S-EPMC3319789 | biostudies-literature
UnknownUrine biomarkers individually and as a consensus model show high sensitivity and specificity for detecting UTIs.
Not available
S-EPMC10829179 | biostudies-literature
UnknownCrystal structures of the components of the Staphylococcus aureus leukotoxin ED.
Not available
S-EPMC4756620 | biostudies-literature
UnknownNext steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy.
Not available
S-EPMC8830302 | biostudies-literature
UnknownImatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.
Not available
S-EPMC4878082 | biostudies-literature
UnknownElevated UTI Biomarkers in Symptomatic Patients with Urine Microbial Densities of 10,000 CFU/mL Indicate a Lower Threshold for Diagnosing UTIs.
Not available
S-EPMC10453813 | biostudies-literature
UnknownCombination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study.
Not available
S-EPMC11188043 | biostudies-literature
UnknownCardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy.
Not available
S-EPMC4986340 | biostudies-literature
UnknownTumor neoantigenicity assessment with CSiN score incorporates clonality and immunogenicity to predict immunotherapy outcomes.
Not available
S-EPMC7239327 | biostudies-literature
Sort   by:  
 Page size